These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

562 related items for PubMed ID: 9301473

  • 1. Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 in the retinal pigment epithelium and interphotoreceptor matrix: vectorial secretion and regulation.
    Padgett LC, Lui GM, Werb Z, LaVail MM.
    Exp Eye Res; 1997 Jun; 64(6):927-38. PubMed ID: 9301473
    [Abstract] [Full Text] [Related]

  • 2. Expression of matrix metalloproteinases and inhibitor by human retinal pigment epithelium.
    Alexander JP, Bradley JM, Gabourel JD, Acott TS.
    Invest Ophthalmol Vis Sci; 1990 Dec; 31(12):2520-8. PubMed ID: 2176183
    [Abstract] [Full Text] [Related]

  • 3. Modulation of matrix metalloproteinase and TIMP-1 expression by cytokines in human RPE cells.
    Eichler W, Friedrichs U, Thies A, Tratz C, Wiedemann P.
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2767-73. PubMed ID: 12147614
    [Abstract] [Full Text] [Related]

  • 4. Secretion of matrix metalloproteinases and their inhibitors (tissue inhibitor of metalloproteinases) by human prostate in explant cultures: reduced tissue inhibitor of metalloproteinase secretion by malignant tissues.
    Lokeshwar BL, Selzer MG, Block NL, Gunja-Smith Z.
    Cancer Res; 1993 Oct 01; 53(19):4493-8. PubMed ID: 7691397
    [Abstract] [Full Text] [Related]

  • 5. Expression of metalloproteinases from human retinal pigment epithelial cells and their effects on the hydraulic conductivity of Bruch's membrane.
    Ahir A, Guo L, Hussain AA, Marshall J.
    Invest Ophthalmol Vis Sci; 2002 Feb 01; 43(2):458-65. PubMed ID: 11818391
    [Abstract] [Full Text] [Related]

  • 6. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
    Zhang X, Sakamoto T, Hata Y, Kubota T, Hisatomi T, Murata T, Ishibashi T, Inomata H.
    Exp Eye Res; 2002 May 01; 74(5):577-84. PubMed ID: 12076079
    [Abstract] [Full Text] [Related]

  • 7. Drusen are Cold Spots for Proteolysis: Expression of Matrix Metalloproteinases and Their Tissue Inhibitor Proteins in Age-related Macular Degeneration.
    Leu ST, Batni S, Radeke MJ, Johnson LV, Anderson DH, Clegg DO.
    Exp Eye Res; 2002 Jan 01; 74(1):141-54. PubMed ID: 11878827
    [Abstract] [Full Text] [Related]

  • 8. Retinal pigment epithelium produces matrix metalloproteinases after laser treatment.
    Flaxel C, Bradle J, Acott T, Samples JR.
    Retina; 2007 Jun 01; 27(5):629-34. PubMed ID: 17558327
    [Abstract] [Full Text] [Related]

  • 9. Characterization and novel activation of 72-kDa metalloproteinase in retinal interphotoreceptor matrix and Y-79 cell culture medium.
    Jones BE, Moshyedi P, Gallo S, Tombran-Tink J, Arand G, Reid DA, Thompson EW, Chader GJ, Waldbillig RJ.
    Exp Eye Res; 1994 Sep 01; 59(3):257-69. PubMed ID: 7821370
    [Abstract] [Full Text] [Related]

  • 10. Synthesis pattern of matrix metalloproteinases (MMPs) and inhibitors (TIMPs) in human explant organ cultures after treatment with latanoprost and dexamethasone.
    el-Shabrawi Y, Eckhardt M, Berghold A, Faulborn J, Auboeck L, Mangge H, Ardjomand N.
    Eye (Lond); 2000 Jun 01; 14 ( Pt 3A)():375-83. PubMed ID: 11027004
    [Abstract] [Full Text] [Related]

  • 11. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors.
    Terada T, Okada Y, Nakanuma Y.
    Hepatology; 1996 Jun 01; 23(6):1341-4. PubMed ID: 8675149
    [Abstract] [Full Text] [Related]

  • 12. Matrix metalloproteinases and metalloproteinase inhibitors in choroidal neovascular membranes.
    Steen B, Sejersen S, Berglin L, Seregard S, Kvanta A.
    Invest Ophthalmol Vis Sci; 1998 Oct 01; 39(11):2194-200. PubMed ID: 9761302
    [Abstract] [Full Text] [Related]

  • 13. Matrix metalloproteinases and their inhibitors.
    Kugler A.
    Anticancer Res; 1999 Oct 01; 19(2C):1589-92. PubMed ID: 10365151
    [Abstract] [Full Text] [Related]

  • 14. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
    Chen RQ, Chen XM, Cui SW, Cai GY, Shi SZ, Xie YS, Lu Y, Peng LX.
    Zhonghua Yi Xue Za Zhi; 2004 Jun 02; 84(11):937-42. PubMed ID: 15329283
    [Abstract] [Full Text] [Related]

  • 15. Production of matrix metalloproteinases at the bone-implant interface in loose total hip replacements.
    Yokohama Y, Matsumoto T, Hirakawa M, Kuroki Y, Fujimoto N, Imai K, Okada Y.
    Lab Invest; 1995 Dec 02; 73(6):899-911. PubMed ID: 8558853
    [Abstract] [Full Text] [Related]

  • 16. Dynamic expression of matrix metalloproteinases (MMP-2, -9 and -14) and the tissue inhibitors of MMPs (TIMP-1, -2 and -3) at the implantation site during tubal pregnancy.
    Bai SX, Wang YL, Qin L, Xiao ZJ, Herva R, Piao YS.
    Reproduction; 2005 Jan 02; 129(1):103-13. PubMed ID: 15615902
    [Abstract] [Full Text] [Related]

  • 17. Localization of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitors for MMPs (TIMPs) in uterine natural killer cells in early human pregnancy.
    Naruse K, Lash GE, Innes BA, Otun HA, Searle RF, Robson SC, Bulmer JN.
    Hum Reprod; 2009 Mar 02; 24(3):553-61. PubMed ID: 19088110
    [Abstract] [Full Text] [Related]

  • 18. Extracellular matrix alterations precede vascularization of the retinal pigment epithelium in dystrophic rats.
    Caldwell RB.
    Curr Eye Res; 1989 Sep 02; 8(9):907-21. PubMed ID: 2477195
    [Abstract] [Full Text] [Related]

  • 19. Relationships between matrix metalloproteinases and tissue inhibitor of metalloproteinases in the wall of abdominal aortic aneurysms.
    Nishimura K, Ikebuchi M, Kanaoka Y, Ohgi S, Ueta E, Nanba E, Ito H.
    Int Angiol; 2003 Sep 02; 22(3):229-38. PubMed ID: 14612849
    [Abstract] [Full Text] [Related]

  • 20. Expression of matrix metalloproteinases and their inhibitors in medulloblastomas and their prognostic relevance.
    Ozen O, Krebs B, Hemmerlein B, Pekrun A, Kretzschmar H, Herms J.
    Clin Cancer Res; 2004 Jul 15; 10(14):4746-53. PubMed ID: 15269148
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.